If You Invested in YS Biopharma Co., Ltd. (YS)
See the YS overviewWhat $1,000 or $10,000 in YS Was Worth at Its Last Close
Real historical value by amount invested and how long before the last close| If you invested | 1 year before | 5 years before | 10 years before | Since Aug 6, 2021 |
|---|---|---|---|---|
| $1,000 | $336 -66% | — | — | $49 -95% |
| $10,000 | $3,363 -66% | — | — | $492 -95% |
Based on real historical closing prices adjusted for stock splits, without dividends, through 2024-07-26. Figures with dividends reinvest each cash dividend at the previous close less the dividend, before taxes. Past performance does not guarantee future results.
Custom Calculation
Choose your own date and amount for YS$1,000 Investment Over Time
YS vs S&P 500Year-by-Year Returns
YS annual performance| Year | Start Price | End Price | Annual Return | Cumulative |
|---|---|---|---|---|
| 2021Aug 6, 2021 to Dec 31, 2021 | $9.71 | $9.72 | +0.1% | +0.1% |
| 2022 | $9.72 | $10.03 | +3.1% | +3.3% |
| 2023 | $10.03 | $0.5110 | -94.9% | -94.7% |
| 2024Dec 29, 2023 to Jul 26, 2024 | $0.5110 | $0.4775 | -6.6% | -95.1% |
About YS Biopharma Co., Ltd.
NASDAQ
Frequently Asked Questions
YS Biopharma Co., Ltd. investment returns
How much was $1,000 invested in YS Biopharma Co., Ltd. worth at its last close?
If you invested $1,000 in YS Biopharma Co., Ltd. (YS) 1 year before its last close, on 2023-07-26, your investment was worth $336 on 2024-07-26, a -66.4% price return without dividends, growing at a compounded rate of -66.3% per year (CAGR).
Has YS Biopharma Co., Ltd. outperformed the S&P 500?
Comparison data requires at least 10 years of trading history. Use the calculator above to compare YS performance over available time periods.
What is YS Biopharma Co., Ltd.'s average annual return?
The compound annual growth rate (CAGR) of YS’s share price over the 1 year to Jul 26, 2024 is -66.3%, without dividends. Individual years vary a great deal, and YS’s best recent full year was 2022 (+3.1%) while the worst was 2023 (-94.9%).
For informational and educational purposes only, not investment advice.
